Capital International Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $511M | Sell |
8,432,445
-12,559,082
| -60% | -$732M | 0.12% | 146 |
|
|
2025
Q4 | $1.13B | Sell |
20,991,527
-11,395,497
| -35% | -$548M | 0.18% | 105 |
|
|
2025
Q3 | $1.46B | Sell |
32,387,024
-33,775,408
| -51% | -$1.58B | 0.24% | 87 |
|
|
2025
Q2 | $3.06B | Sell |
66,162,432
-303,341
| -0.5% | -$14.9M | 0.53% | 48 |
|
|
2025
Q1 | $4.05B | Buy |
66,465,773
+20,599,149
| +45% | +$1.2B | 0.8% | 29 |
|
|
2024
Q4 | $2.59B | Buy |
45,866,624
+3,218,865
| +8% | +$180M | 0.49% | 53 |
|
|
2024
Q3 | $2.21B | Sell |
42,647,759
-12,758,833
| -23% | -$599M | 0.42% | 66 |
|
|
2024
Q2 | $2.3B | Sell |
55,406,592
-14,797,222
| -21% | -$662M | 0.47% | 58 |
|
|
2024
Q1 | $3.81B | Buy |
70,203,814
+8,675,322
| +14% | +$442M | 0.77% | 31 |
|
|
2023
Q4 | $3.16B | Sell |
61,528,492
-7,891,438
| -11% | -$414M | 0.71% | 37 |
|
|
2023
Q3 | $4.03B | Buy |
69,419,930
+123,924
| +0.2% | +$7.59M | 1.02% | 21 |
|
|
2023
Q2 | $4.43B | Buy |
69,296,006
+7,878,833
| +13% | +$528M | 1.07% | 21 |
|
|
2023
Q1 | $4.26B | Buy |
61,417,173
+8,700,136
| +17% | +$614M | 1.1% | 18 |
|
|
2022
Q4 | $3.79B | Buy |
52,717,037
+320,605
| +0.6% | +$24.2M | 1.02% | 19 |
|
|
2022
Q3 | $3.73B | Buy |
52,396,432
+14,298,520
| +38% | +$1.04B | 1.09% | 16 |
|
|
2022
Q2 | $2.93B | Buy |
38,097,912
+15,196,981
| +66% | +$1.16B | 0.8% | 30 |
|
|
2022
Q1 | $1.67B | Buy |
+22,900,931
| New | +$1.54B | 0.38% | 73 |
|
|
2017
Q3 | – | Sell |
-160,401
| Closed | -$8.94M | – | 240 |
|
|
2017
Q2 | $8.94M | Buy |
160,401
+1
| +0% | +$54 | 0.01% | 231 |
|
|
2017
Q1 | $8.72M | Hold |
160,400
| – | – | 0.01% | 234 |
|
|
2016
Q4 | $9.37M | Sell |
160,400
-192,400
| -55% | -$10.5M | 0.01% | 232 |
|
|
2016
Q3 | $19M | Hold |
352,800
| – | – | 0.03% | 232 |
|
|
2016
Q2 | $25.9M | Sell |
352,800
-92,800
| -21% | -$6.56M | 0.04% | 224 |
|
|
2016
Q1 | $28.5M | Sell |
445,600
-1,997,200
| -82% | -$126M | 0.04% | 221 |
|
|
2015
Q4 | $168M | Buy |
2,442,800
+2,350,000
| +2,532% | +$155M | 0.26% | 112 |
|
|
2015
Q3 | $5.49M | Sell |
92,800
-12,277,491
| -99% | -$779M | 0.01% | 253 |
|
|
2015
Q2 | $823M | Sell |
12,370,291
-3,311,394
| -21% | -$218M | 1.4% | 12 |
|
|
2015
Q1 | $1.01B | Sell |
15,681,685
-111,500
| -0.7% | -$6.98M | 1.84% | 6 |
|
|
2014
Q4 | $932M | Buy |
15,793,185
+945,775
| +6% | +$53.3M | 1.9% | 6 |
|
|
2014
Q3 | $760M | Buy |
14,847,410
+954,460
| +7% | +$47.7M | 1.85% | 8 |
|
|
2014
Q2 | $674M | Sell |
13,892,950
-2,271,350
| -14% | -$112M | 1.74% | 8 |
|
|
2014
Q1 | $840M | Buy |
16,164,300
+144,800
| +0.9% | +$7.7M | 2.26% | 3 |
|
|
2013
Q4 | $851M | Buy |
16,019,500
+8,550,000
| +114% | +$436M | 2.64% | 2 |
|
|
2013
Q3 | $346M | Hold |
7,469,500
| – | – | 1.48% | 9 |
|
|
2013
Q2 | $334M | Buy |
+7,469,500
| New | +$324M | 1.52% | 8 |
|
Other funds holding BMY
VCM
VPM
Capital International Investors's BMY Position: Q1 2026 in Review
Capital International Investors reduced its Bristol-Myers Squibb (BMY) stake by 60% in Q1 2026, selling an estimated $732M and leaving 8,432,445 shares worth $511M. The position accounts for 0.12% of the portfolio, ranked #146.
Capital International Investors first reported a position in BMY in Q2 2013 and has held it in 34 quarters since. The position peaked at $4.43B in Q2 2023. 2,524 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Capital International Investors held 8,432,445 shares of Bristol-Myers Squibb worth $511M as of Q1 2026.
- Capital International Investors sold 12,559,082 Bristol-Myers Squibb shares in Q1 2026, an estimated $732M.
- Bristol-Myers Squibb made up 0.12% of Capital International Investors's portfolio in Q1 2026, its #146 holding.
- Capital International Investors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 34 quarters since.
- Capital International Investors's Bristol-Myers Squibb position peaked at $4.43B in Q2 2023.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.